MARKETS21:39 UTC1d ago 1 min readSource: MarketWatch
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides
Image via MarketWatch
Hims & Hers Health’s plan to enter the business of selling peptides is looking a lot more realistic.
AI Executive Brief
- / Hims & Hers stock rises due to potential entry into peptide sales.
- / U.S. moves to reassess peptides, benefiting Hims & Hers' business plan.
- / Positive outlook for Hims & Hers in the peptide market.
AI-generated summary for informational purposes. Verify with original source.
More from The Global Wire
View All
MARKETS7h ago
Citizens Financial: Solid Q1 Shows No Signs Of Economic Weakness
MARKETS7h ago
Zonda exchange says 4.5K BTC wallet inaccessible amid withdrawal crisis
MARKETS7h ago
Retail traders pile into Allbirds after odd AI pivot. History shows it won't end well
MARKETS7h ago
Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance
MARKETS8h ago
General Mills announces €1.7 billion notes offering due 2056
MARKETS8h ago
First Horizon: A Decent Start, But Follow Through Is Key
Stay ahead of every story
The Global Wire — Live Front Page
Real-time AI-powered news from 55+ sources. Breaking stories, market signals, sports, geopolitics — all in one place.
Explore The Global WireFree • No login required • Updated every 15 minutes